Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04435366 |
|---|---|
| Brief Title: | A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) |
| First Submitted : | May 12, 2020 |
| First Submitted that Met QC Criteria : | June 15, 2020 |
| First Posted : | June 17, 2020 |
| Last Update Submitted that Met QC Criteria : | September 26, 2022 |
| Last Update Posted : | September 28, 2022 |